Variant report
Variant | rs6599282 |
---|---|
Chromosome Location | chr4:1108407-1108408 |
allele | A/G |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000212458 | Chromatin interaction |
ENSG00000196810 | Chromatin interaction |
ENSG00000159692 | Chromatin interaction |
rs_ID | r2[population] |
---|---|
rs10002248 | 1.00[CEU][hapmap];0.84[MKK][hapmap] |
rs10002437 | 1.00[CEU][hapmap];0.84[MKK][hapmap] |
rs10003030 | 0.87[ASW][hapmap];0.84[LWK][hapmap];0.89[YRI][hapmap];0.85[AFR][1000 genomes] |
rs10014245 | 1.00[ASW][hapmap];1.00[CEU][hapmap];0.93[LWK][hapmap];1.00[MKK][hapmap];1.00[YRI][hapmap];0.95[AFR][1000 genomes] |
rs10015944 | 0.97[AFR][1000 genomes] |
rs10016588 | 0.93[YRI][hapmap];0.91[AFR][1000 genomes] |
rs10032349 | 0.80[EUR][1000 genomes] |
rs10032470 | 0.88[CEU][hapmap];0.80[EUR][1000 genomes] |
rs10033163 | 0.88[CEU][hapmap];0.83[EUR][1000 genomes] |
rs11724989 | 0.88[CEU][hapmap] |
rs11726554 | 0.94[AFR][1000 genomes] |
rs11728360 | 0.97[AMR][1000 genomes];0.94[EUR][1000 genomes] |
rs11731643 | 0.85[AFR][1000 genomes] |
rs11731685 | 0.95[AFR][1000 genomes] |
rs11736950 | 0.93[AMR][1000 genomes];0.97[EUR][1000 genomes] |
rs13119696 | 1.00[CEU][hapmap];0.83[EUR][1000 genomes] |
rs1383660 | 0.88[CEU][hapmap];1.00[GIH][hapmap];0.82[TSI][hapmap];0.80[EUR][1000 genomes] |
rs1481167 | 1.00[CEU][hapmap];1.00[YRI][hapmap];1.00[AFR][1000 genomes];0.97[AMR][1000 genomes];0.97[EUR][1000 genomes] |
rs17164384 | 1.00[ASW][hapmap];1.00[CEU][hapmap];0.97[LWK][hapmap];0.96[MKK][hapmap];0.96[YRI][hapmap];0.94[AFR][1000 genomes] |
rs28540372 | 0.81[AFR][1000 genomes] |
rs28621675 | 0.98[AFR][1000 genomes] |
rs28785628 | 0.98[AFR][1000 genomes] |
rs28856334 | 0.88[AFR][1000 genomes] |
rs2924495 | 0.88[CEU][hapmap];1.00[GIH][hapmap];0.82[TSI][hapmap];0.80[EUR][1000 genomes] |
rs3775111 | 0.89[YRI][hapmap];0.82[AFR][1000 genomes] |
rs4246683 | 0.83[EUR][1000 genomes] |
rs4246684 | 0.88[CEU][hapmap];1.00[GIH][hapmap];0.82[TSI][hapmap];0.83[EUR][1000 genomes] |
rs4974561 | 1.00[CEU][hapmap];0.80[EUR][1000 genomes] |
rs4974569 | 0.88[CEU][hapmap];0.83[EUR][1000 genomes] |
rs4974571 | 0.88[CEU][hapmap];0.83[EUR][1000 genomes] |
rs4974573 | 0.88[CEU][hapmap] |
rs4974628 | 0.88[CEU][hapmap];0.80[EUR][1000 genomes] |
rs4974637 | 0.80[EUR][1000 genomes] |
rs4974639 | 0.88[CEU][hapmap];0.80[EUR][1000 genomes] |
rs4974642 | 0.88[CEU][hapmap];0.80[EUR][1000 genomes] |
rs4974643 | 0.88[CEU][hapmap];0.80[EUR][1000 genomes] |
rs4974644 | 0.88[CEU][hapmap];1.00[GIH][hapmap];0.82[TSI][hapmap];0.80[EUR][1000 genomes] |
rs588824 | 0.88[CEU][hapmap] |
rs589660 | 0.88[CEU][hapmap];0.80[EUR][1000 genomes] |
rs59465697 | 0.95[AFR][1000 genomes] |
rs604526 | 0.85[CEU][hapmap] |
rs606327 | 0.88[CEU][hapmap] |
rs608066 | 0.86[CEU][hapmap] |
rs614945 | 0.88[CEU][hapmap] |
rs615381 | 0.88[CEU][hapmap];1.00[GIH][hapmap];0.82[TSI][hapmap] |
rs616569 | 0.88[CEU][hapmap];0.80[EUR][1000 genomes] |
rs619407 | 0.88[CEU][hapmap];0.80[EUR][1000 genomes] |
rs620398 | 0.88[CEU][hapmap];0.80[EUR][1000 genomes] |
rs629638 | 0.88[CEU][hapmap] |
rs632319 | 0.88[CEU][hapmap];0.80[EUR][1000 genomes] |
rs633087 | 0.88[CEU][hapmap];0.80[EUR][1000 genomes] |
rs633141 | 0.88[CEU][hapmap];1.00[GIH][hapmap];0.82[TSI][hapmap];0.80[EUR][1000 genomes] |
rs633599 | 0.88[CEU][hapmap];0.80[EUR][1000 genomes] |
rs633954 | 0.88[CEU][hapmap];1.00[GIH][hapmap];0.82[TSI][hapmap] |
rs643043 | 1.00[CEU][hapmap] |
rs646117 | 0.80[EUR][1000 genomes] |
rs647828 | 0.80[EUR][1000 genomes] |
rs648640 | 0.80[EUR][1000 genomes] |
rs649243 | 0.88[CEU][hapmap] |
rs649258 | 0.80[EUR][1000 genomes] |
rs649616 | 0.88[CEU][hapmap];0.92[GIH][hapmap];0.82[TSI][hapmap];0.80[EUR][1000 genomes] |
rs6599283 | 1.00[ASW][hapmap];1.00[CEU][hapmap];1.00[GIH][hapmap];1.00[LWK][hapmap];1.00[MKK][hapmap];0.95[TSI][hapmap];1.00[YRI][hapmap];1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];0.97[EUR][1000 genomes] |
rs6599284 | 1.00[CEU][hapmap];0.86[MKK][hapmap] |
rs6599285 | 1.00[CEU][hapmap] |
rs661364 | 0.80[EUR][1000 genomes] |
rs671790 | 0.88[CEU][hapmap] |
rs6812059 | 0.82[AFR][1000 genomes] |
rs6814094 | 0.80[EUR][1000 genomes] |
rs6817989 | 0.88[CEU][hapmap];0.92[GIH][hapmap] |
rs681857 | 0.88[CEU][hapmap];1.00[GIH][hapmap];0.82[TSI][hapmap];0.80[EUR][1000 genomes] |
rs682243 | 0.88[CEU][hapmap];0.80[EUR][1000 genomes] |
rs682787 | 0.88[CEU][hapmap];0.80[EUR][1000 genomes] |
rs6831018 | 0.90[AFR][1000 genomes] |
rs6836158 | 1.00[ASW][hapmap];1.00[CEU][hapmap];1.00[LWK][hapmap];1.00[MKK][hapmap];1.00[YRI][hapmap];1.00[AFR][1000 genomes] |
rs6836335 | 1.00[CEU][hapmap] |
rs6839768 | 0.88[CEU][hapmap];1.00[GIH][hapmap];0.80[TSI][hapmap];0.84[EUR][1000 genomes] |
rs6840162 | 0.88[CEU][hapmap];0.80[EUR][1000 genomes] |
rs6840347 | 1.00[GIH][hapmap];1.00[MEX][hapmap] |
rs73067706 | 0.86[AFR][1000 genomes] |
rs73067775 | 0.94[AFR][1000 genomes] |
rs73067776 | 0.94[AFR][1000 genomes] |
rs73072227 | 0.80[AMR][1000 genomes] |
rs7661069 | 0.81[ASW][hapmap];0.82[LWK][hapmap];0.86[YRI][hapmap];0.84[AFR][1000 genomes] |
rs7669287 | 0.87[ASW][hapmap];0.84[LWK][hapmap];0.89[YRI][hapmap];0.82[AFR][1000 genomes] |
rs7676956 | 1.00[ASW][hapmap];1.00[CEU][hapmap];0.97[LWK][hapmap];1.00[MKK][hapmap];1.00[YRI][hapmap];1.00[AFR][1000 genomes] |
rs7679718 | 1.00[CEU][hapmap];0.86[MKK][hapmap] |
rs7684536 | 1.00[CEU][hapmap];1.00[YRI][hapmap];1.00[AFR][1000 genomes] |
rs7685051 | 0.98[AFR][1000 genomes] |
rs7690300 | 1.00[CEU][hapmap];1.00[YRI][hapmap];1.00[AFR][1000 genomes] |
rs7690832 | 1.00[ASW][hapmap];1.00[CEU][hapmap];0.97[LWK][hapmap];1.00[MKK][hapmap];1.00[YRI][hapmap];0.95[AFR][1000 genomes] |
rs878324 | 0.85[AFR][1000 genomes] |
rs9992322 | 1.00[CEU][hapmap] |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | nsv822425 | chr4:540105-1413799 | Weak transcription Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Enhancers ZNF genes & repeats Strong transcription Bivalent Enhancer Bivalent/Poised TSS Genic enhancers Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 108 gene(s) | inside rSNPs | diseases |
2 | nsv530490 | chr4:614355-1399150 | Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription Genic enhancers ZNF genes & repeats Strong transcription Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 104 gene(s) | inside rSNPs | diseases |
3 | nsv536980 | chr4:827866-1167377 | Active TSS Weak transcription Flanking Bivalent TSS/Enh Strong transcription Genic enhancers Enhancers Bivalent Enhancer Flanking Active TSS Bivalent/Poised TSS ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 40 gene(s) | inside rSNPs | diseases |
4 | nsv1009619 | chr4:901897-1215657 | Strong transcription Weak transcription ZNF genes & repeats Flanking Active TSS Enhancers Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Genic enhancers Bivalent/Poised TSS Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 43 gene(s) | inside rSNPs | diseases |
5 | nsv1003876 | chr4:927509-1191316 | Weak transcription Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Strong transcription Active TSS Genic enhancers ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 37 gene(s) | inside rSNPs | diseases |
6 | nsv1000381 | chr4:927509-1198766 | Weak transcription Enhancers Genic enhancers Flanking Bivalent TSS/Enh Strong transcription Active TSS Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 38 gene(s) | inside rSNPs | diseases |
7 | esv3339080 | chr4:970630-1546223 | Active TSS Flanking Active TSS Bivalent/Poised TSS Enhancers Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh ZNF genes & repeats Strong transcription Genic enhancers Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 82 gene(s) | inside rSNPs | diseases |
8 | nsv1004727 | chr4:1015652-1158207 | Enhancers Strong transcription Bivalent Enhancer Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Weak transcription Genic enhancers Bivalent/Poised TSS ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 19 gene(s) | inside rSNPs | diseases |
9 | nsv536984 | chr4:1015652-1158207 | Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Active TSS Bivalent/Poised TSS Genic enhancers Strong transcription ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 19 gene(s) | inside rSNPs | diseases |
10 | nsv1005990 | chr4:1015652-1167619 | Flanking Bivalent TSS/Enh Bivalent Enhancer Strong transcription Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Genic enhancers ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 22 gene(s) | inside rSNPs | diseases |
11 | nsv1000594 | chr4:1045099-1129975 | Enhancers Bivalent/Poised TSS Weak transcription Flanking Bivalent TSS/Enh Genic enhancers Bivalent Enhancer Flanking Active TSS Active TSS Strong transcription ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 13 gene(s) | inside rSNPs | diseases |
12 | nsv1001165 | chr4:1051512-1129975 | Enhancers Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Transcr. at gene 5' and 3' Weak transcription Genic enhancers Strong transcription ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNA | 11 gene(s) | inside rSNPs | diseases |
13 | nsv1012892 | chr4:1086871-1176630 | Enhancers Bivalent Enhancer Weak transcription Transcr. at gene 5' and 3' Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh ZNF genes & repeats Genic enhancers Strong transcription | TF binding regionCpG islandChromatin interactive regionlncRNA | 17 gene(s) | inside rSNPs | diseases |
14 | nsv829835 | chr4:1097586-1304239 | Enhancers Genic enhancers Flanking Active TSS Active TSS Bivalent Enhancer Weak transcription ZNF genes & repeats Strong transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 59 gene(s) | inside rSNPs | diseases |
15 | esv3440980 | chr4:1105477-1108525 | Bivalent Enhancer Bivalent/Poised TSS Weak transcription Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Active TSS Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 5 gene(s) | inside rSNPs | diseases |
16 | esv3374334 | chr4:1105777-1108900 | Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 5 gene(s) | inside rSNPs | diseases |
17 | esv3375020 | chr4:1106377-1109125 | Flanking Bivalent TSS/Enh Bivalent/Poised TSS Flanking Active TSS Weak transcription Bivalent Enhancer Active TSS Enhancers Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 5 gene(s) | inside rSNPs | diseases |
No data |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:1104600-1109600 | Weak transcription | Fetal Kidney | kidney |
2 | chr4:1107000-1108600 | Bivalent/Poised TSS | iPS-18 Cell Line | embryonic stem cell |
3 | chr4:1107400-1108600 | Active TSS | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
4 | chr4:1107600-1108600 | Weak transcription | Esophagus | oesophagus |
5 | chr4:1107600-1108800 | Enhancers | Colonic Mucosa | Colon |
6 | chr4:1107800-1109200 | Weak transcription | Pancreatic Islets | Pancreatic Islet |
7 | chr4:1108200-1108600 | Bivalent/Poised TSS | ES-WA7 Cell Line | embryonic stem cell |
8 | chr4:1108200-1108600 | Enhancers | Adipose Nuclei | Adipose |
9 | chr4:1108200-1108600 | Weak transcription | Pancreas | Pancrea |
10 | chr4:1108200-1109000 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
11 | chr4:1108200-1109600 | Weak transcription | Duodenum Mucosa | Duodenum |
12 | chr4:1108400-1108600 | Enhancers | Primary T helper cells fromperipheralblood | blood |
13 | chr4:1108400-1108600 | Flanking Bivalent TSS/Enh | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
14 | chr4:1108400-1108600 | Flanking Active TSS | Hela-S3 | cervix |
15 | chr4:1108400-1108600 | Enhancers | Osteobl | bone |
16 | chr4:1108400-1108800 | Bivalent Enhancer | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |